Karcher Solveigh C, Laufer Stefan A
Institute of Pharmacy, Department of Pharmaceutical and Medicinal Chemistry, Eberhard-Karls-Universität, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
J Med Chem. 2009 Mar 26;52(6):1778-82. doi: 10.1021/jm801291f.
We recently described a promising novel class of p38 mitogen activated protein (MAP()) kinase inhibitors with dibenzepinone-scaffolds. To optimize their physicochemical properties, characterized by calculated log P values and measured lipophilicity (chromatographic hydrophobicity index = CHI), we synthesized aza-analogue dibenzepinones. Here, we present the synthesis and biological data of compounds with the novel aza-dibenzepinone scaffolds. Although these aza-analogues revealed an improved aqueous solubility, introduction of nitrogen was not effective in the p38 MAPK enzyme assay.
我们最近描述了一类很有前景的新型p38丝裂原活化蛋白(MAP)激酶抑制剂,其具有二苯并氮杂卓骨架。为了优化它们以计算得到的log P值和测得的亲脂性(色谱疏水指数 = CHI)为特征的物理化学性质,我们合成了氮杂类似物二苯并氮杂卓。在此,我们展示了具有新型氮杂二苯并氮杂卓骨架的化合物的合成及生物学数据。尽管这些氮杂类似物显示出改善的水溶性,但在p38丝裂原活化蛋白激酶酶分析中引入氮并不有效。